![](/img/cover-not-exists.png)
1018PProgression of disease within 2 years (POD24) is a clinically significant endpoint to identify follicular lymphoma patients with high risk of death
Sortais, C, Lok, A, Gastinne, T, Mahé, B, Dubruille, V, Blin, N, Howlett, S, Tabah, A, Arnaud, P, Moreau, A, Moreau, P, Leux, C, Le Gouill, SVolume:
29
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy286.014
Date:
October, 2018
File:
PDF, 75 KB
english, 2018